University College London Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
European Molecular Biology Laboratory (Heidelberg) Featured PhD Programmes
"pancreatic" AND "cancer"…×
10 miles

pancreatic cancer PhD Projects, Programs & Scholarships

We have 12 pancreatic cancer PhD Projects, Programs & Scholarships

  • "pancreatic" AND "cancer" ×
  • clear all
Order by 
Showing 1 to 10 of 12
  Molecular mechanisms regulating the developmental plasticity of pancreatic cancer cells #NDORMS-2020/6
  Dr S Pauklin
Application Deadline: 10 January 2020

Funding Type

PhD Type

Pancreatic cancers are among the most lethal malignancies in human due to highly metastatic characteristics and the poor responsiveness to currently used cancer therapeutics.
  Delay to diagnosis and treatment in pancreatic cancer with patients, caregivers and healthcare professionals
  Prof A Topping
Applications accepted all year round

Funding Type

PhD Type

Applications are invited for a 3-year full time self-funded PhD Studentship (part time would be considered). Patients with pancreatic cancer are commonly diagnosed with advanced disease.
  Fibroblast Heterogeneity in Pancreatic Cancer
  Dr G Biffi
Application Deadline: 15 November 2019

Funding Type

PhD Type

In pancreatic cancer, cancer-associated fibroblasts (CAFs) have been shown to promote tumour growth, chemotherapy resistance and immunosuppression by secreting ligands and extracellular matrix proteins.
  Identifying genomic and epigenetic factors in different subtypes of pancreatic cancer
  Prof J Carroll
Application Deadline: 15 November 2019

Funding Type

PhD Type

Despite recent advances in the treatment of pancreatic adenocarcinoma (PDAC), the median survival remains. Epigenetic pathway alterations are an emerging mechanism for PDA progression.
  Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
  Dr J Bruce, Prof K Williams, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy.
  Inhibition of PRMT5 as a cancer therapy
  Dr K. Sheppard
Applications accepted all year round

Funding Type

PhD Type

Targeted therapy has had profound impact on outcomes for cancer patients.
  FGFR signalling in breast cancer
  Dr A Chioni
Applications accepted all year round

Funding Type

PhD Type

Growth factors are used during development to convey messages that tell cells to divide, survive, migrate and adopt a particular fate.
  Neutrophils and Chemokine Signalling in the Tumour Immune Micro-environment and Progression
  Dr T Iwata
Applications accepted all year round

Funding Type

PhD Type

Checkpoint inhibitor immunotherapy is promising, however still requires an improvement in response and development of markers to predict the patients who would benefit from this therapy.
  Multimerisation of ELAV/Hu proteins – a key mechanism ensuring specificity for RNA recognition in health and disease
  Dr M Soller, Dr T Knowles
Applications accepted all year round

Funding Type

PhD Type

Aims. Determine the structure of the ELAV dodecameric complex bound to target RNA by cryoEM and functionally probe interaction interfaces in vitro and in vivo in transgenic Drosophila models for neurodegeneration and cancer.
  The role of matrix interactions in regulating the SPARC family of matricellular proteins.
  Dr N Hill, Dr A Munasinghe
Applications accepted all year round

Funding Type

PhD Type

The SPARC family of matricellular proteins determine the way in which cells respond to their extracellular environment. SPARC family proteins interact with a range of binding partners, including matrix proteins (1).
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.